GlassScriptPhysician profile
Cordelia N Uddoh
NPI 1821179243
$457.93
in general payments reported to CMS, 2019-2025
9 companies · $51.73 in 2025
The $51.73 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.23 · 2020: $227 · 2021: $40.46 · 2022: $19.59 · 2023: $19.80 · 2024: $20.63 · 2025: $51.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $158.13 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $105.15 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $46.26 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $39.39 | 2022-2023 | Prolensa, Lotemax Sm, Vyzulta |
| Sun Pharmaceutical Industries INC. | $34.57 | 2025 | |
| Amgen INC. | $20.63 | 2024 | Tepezza |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Sight Sciences, INC. | $17.16 | 2025 | Sion Surgical Instrument, Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cordelia Uddoh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.